Abstract
We describe a cohort of three patients with variable neurological presentations by SARS-COV-2 infection. It includes one case each of acute cerebellitis, acute encephalomyelitis and arterial ischemic stroke. To the best of our knowledge, we report the first pediatric case of acute cerebellitis due to SARS-CoV-2 infection. All critically ill patients were treated with methylprednisolone pulse therapy and dexamethasone. Patient with acute cerebellitis in addition required intravenous immunoglobulin infusion. All the patients responded to the treatment with complete neurological recovery.
All Keywords
【초록키워드】 Dexamethasone, Methylprednisolone, Treatment, Intravenous immunoglobulin, therapy, knowledge, stroke, SARS-COV-2 infection, pediatric, Infection, Cohort, Patient, neurological, Critically ill patient, pulse, Complete, include, addition, required, treated, All the patient, 【제목키워드】 COVID-19, clinical, Spectrum, manifestation, Sery,
【초록키워드】 Dexamethasone, Methylprednisolone, Treatment, Intravenous immunoglobulin, therapy, knowledge, stroke, SARS-COV-2 infection, pediatric, Infection, Cohort, Patient, neurological, Critically ill patient, pulse, Complete, include, addition, required, treated, All the patient, 【제목키워드】 COVID-19, clinical, Spectrum, manifestation, Sery,
{{{ 추상적인 }}}
우리는 SARS-COV-2 감염에 의한 다양한 신경학적 표현을 가진 3명의 환자의 코호트를 설명합니다. 급성 소뇌염, 급성 뇌척수염 및 동맥 허혈성 뇌졸중 각각 1건을 포함한다. 우리가 아는 한, 우리는 SARS-CoV-2 감염으로 인한 급성 소뇌염의 첫 번째 소아 증례를 보고합니다. 모든 중환자는 메틸프레드니솔론 펄스 요법과 덱사메타손으로 치료되었습니다. 급성 소뇌염이 있는 환자는 추가로 정맥 면역글로불린 주입이 필요했습니다. 모든 환자는 완전한 신경학적 회복으로 치료에 반응했습니다.